Models of T cell anergy: is there a common molecular mechanism?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

112 citing papers in PubMed.

1. Cellular Components of the Tumor Environment in Gliomas-What Do We Know Today?Biomedicines · 2023
   Review
2. The interplay of inflammation, exosomes and CaCardiovascular diabetology · 2023
   Review
3. The optimized core peptide derived from CABIN1 efficiently inhibits calcineurin-mediated T-cell activation.Experimental & molecular medicine · 2022
   Article
4. Mapping CAR T-Cell Design Space Using Agent-Based Models.Frontiers in molecular biosciences · 2022
   Article
5. Effect of Cellular-Based Artificial Antigen Presenting Cells Expressing ICOSL, in T-cell Subtypes Differentiation and Activation.Advanced pharmaceutical bulletin · 2021
   Article
6. [The ambiguous role of the inflammatory micromilieu in solid tumors].Der Pathologe · 2020
   Review
7. Optimization of T-cell Receptor-Modified T Cells for Cancer Therapy.Cancer immunology research · 2020
   Article
8. CaMKII Activity in the Inflammatory Response of Cardiac Diseases.International journal of molecular sciences · 2019
   Review
9. Engagement of distinct epitopes on CD43 induces different co-stimulatory pathways in human T cells.Immunology · 2016
   Article
10. Immunoregulatory pathways following strong inflammatory processes markedly impair CD4+ T cell responses.Human vaccines & immunotherapeutics · 2016
    Review
11. Induction of tolerance against the arthritogenic antigen with type-II collagen peptide-linked soluble MHC class II molecules.BMB reports · 2016
    Article
12. Nanoscale Relationship Between CD4 and CD25 of T Cells Visualized with NSOM/QD-Based Dual-Color Imaging System.Nanoscale research letters · 2015
    Article
13. Expanding regulatory T cells alleviates chikungunya virus-induced pathology in mice.Journal of virology · 2015
    Article
14. TLR7 induces anergy in human CD4(+) T cells.Nature immunology · 2015
    Article
15. Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity.Frontiers in immunology · 2015
    Review
16. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses.Nature reviews. Immunology · 2014
    Review
17. Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.Stem cell reviews and reports · 2014
    Review
18. Modulation of the human T cell response by a novel non-mitogenic anti-CD3 antibody.PloS one · 2014
    Article
19. Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models.Frontiers in immunology · 2013
    Review
20. Human iPS cell-derived hematopoietic progenitor cells induce T-cell anergy in in vitro-generated alloreactive CD8(+) T cells.Blood · 2013
    Article

52 more citing papers are in PubMed but not listed here.

Corrections and comments

• Comment on
  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.1996

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as